YU233676A - Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides - Google Patents

Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides

Info

Publication number
YU233676A
YU233676A YU02336/76A YU233676A YU233676A YU 233676 A YU233676 A YU 233676A YU 02336/76 A YU02336/76 A YU 02336/76A YU 233676 A YU233676 A YU 233676A YU 233676 A YU233676 A YU 233676A
Authority
YU
Yugoslavia
Prior art keywords
arylacetamides
piperidinyl
aryl
obtaining new
obtaining
Prior art date
Application number
YU02336/76A
Other versions
YU39973B (en
Inventor
S Sanczuk
F K H Hermans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of YU233676A publication Critical patent/YU233676A/en
Publication of YU39973B publication Critical patent/YU39973B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU2336/76A 1975-09-23 1976-09-22 Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides YU39973B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
YU233676A true YU233676A (en) 1983-01-21
YU39973B YU39973B (en) 1985-06-30

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2336/76A YU39973B (en) 1975-09-23 1976-09-22 Process for obtaining n-aryl-n-(4-piperidinyl)-arylacetamides

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
AU2008240727C1 (en) * 2007-04-23 2013-10-03 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
CN101663292A (en) 2007-04-23 2010-03-03 詹森药业有限公司 4-alkoxypyridazine derivatives as quick dissociated dopamine 2 receptor antagonists
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
CN102159554B (en) 2008-07-03 2014-09-24 詹森药业有限公司 Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
LT2307374T (en) 2008-07-31 2017-04-25 Janssen Pharmaceutica Nv Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
GR58469B (en) 1977-10-14
FR2325377B1 (en) 1980-04-18
HU172964B (en) 1979-01-28
PH12497A (en) 1979-04-05
RO70079A (en) 1982-10-26
LU75837A1 (en) 1977-05-04
JPS5239683A (en) 1977-03-28
FI61482C (en) 1982-08-10
NZ181972A (en) 1978-07-28
CH628623A5 (en) 1982-03-15
AU510029B2 (en) 1980-06-05
DE2642856C2 (en) 1990-06-21
AU1787876A (en) 1978-03-23
PL192578A1 (en) 1979-02-26
ES451768A1 (en) 1978-05-01
FI762698A (en) 1977-03-24
NO763054L (en) 1977-03-24
JPS6016417B2 (en) 1985-04-25
BG27543A3 (en) 1979-11-12
SU747424A3 (en) 1980-07-23
CS222663B2 (en) 1983-07-29
NO147672C (en) 1983-05-25
FI61482B (en) 1982-04-30
YU39973B (en) 1985-06-30
PL117323B1 (en) 1981-07-31
IL50522A (en) 1979-09-30
NL187267B (en) 1991-03-01
IE43802B1 (en) 1981-06-03
SE427839B (en) 1983-05-09
NL7610513A (en) 1977-03-25
DK150478C (en) 1987-10-05
CA1068271A (en) 1979-12-18
IE43802L (en) 1977-03-23
IT1073893B (en) 1985-04-17
GB1539473A (en) 1979-01-31
PT65631A (en) 1976-10-01
ATA702976A (en) 1981-02-15
PT65631B (en) 1978-07-05
SE7610501L (en) 1977-03-24
DK427876A (en) 1977-03-24
NL187267C (en) 1991-08-01
DE2642856A1 (en) 1977-03-24
FR2325377A1 (en) 1977-04-22
DK150478B (en) 1987-03-09
IL50522A0 (en) 1976-11-30
NO147672B (en) 1983-02-14
AT363935B (en) 1981-09-10

Similar Documents

Publication Publication Date Title
YU262076A (en) Process for obtaining 2-phenyl-3-aroylbenzothiophene
YU203476A (en) Process for obtaining new sulfonyl-benzimidazole compounds
YU140576A (en) Process for obtaining nifamycin compounds
HU175583B (en) Process for preparing new polyhalosteroids
HU172100B (en) Process for preparing new biphenyloxy-derivatives
HU177882B (en) Process for preparing new imidazolyl-alkyl-sulphides
YU100676A (en) Process for obtaining piperazinylpyrazine
YU147976A (en) Process for obtaining 11-deoxy-16-aryloxy-omega-tetranoprostaglandin
GB1548032A (en) Process for preparing amono-acid admides
CS185596B2 (en) Process for preparing new propargyl-2-phenylamino-2-imidazolines
YU40141B (en) Process for obtaining new eburnamenine derivatives
YU233676A (en) Process for obtaining new n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
HU175215B (en) Process for preparing new pyridine-carboxamides
GB1554153A (en) Process for making 2-amino-2-alkylthionitroethylenes
YU39771B (en) Process for preparing new homo-phthalimides
YU121176A (en) Process for obtaining rifamcin compounds
YU196776A (en) Process for obtaining phosphor-dichlorido-thiolate
HU171166B (en) Process for preparing new epoxy-androstanes
GB1542488A (en) Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile
YU40621B (en) Process for obtaining 6-methoxy-alpha-carboxy-penicillin
YU262276A (en) Process for obtaining aroyl-phenyl naphthalines
YU71576A (en) Process for preparing new oxime-ethers
YU40642B (en) Process for preparing for preparing new substituted arylalklamines
HU172553B (en) Process for producing -3-acyloxymethyl-cepheme- and -3-thiomethyl-cepheme- derivatives
GB1543929A (en) Process for preparing dihalovinylcyclopropane-carboxylates